Skip to main content
Senti Biosciences, Inc. logo

Senti Biosciences, Inc. — Investor Relations & Filings

Ticker · SNTI ISIN · US81726A1007 US Professional, scientific and technical activities
Filings indexed 318 across all filing types
Latest filing 2022-11-10 Regulatory Filings
Country US United States of America
Listing US SNTI

About Senti Biosciences, Inc.

https://www.sentibio.com/

Senti Biosciences, Inc. is a clinical-stage biotechnology company developing a new generation of cell and gene therapies. The company's core technology is its synthetic biology platform, which designs and optimizes proprietary "Gene Circuits." These circuits, created from novel combinations of DNA sequences, are engineered to reprogram cells with biological logic, enabling them to sense inputs, compute decisions, and respond to their cellular environments. This approach aims to create smarter medicines with enhanced therapeutic effectiveness and safety. Senti Bio is applying its Gene Circuit technology to develop a pipeline of product candidates, primarily for the treatment of cancer, designed to precisely target and eliminate malignant cells while sparing healthy tissue.

Recent filings

Filing Released Lang Actions
424B3
Regulatory Filings
2022-11-10 English
424B3
Regulatory Filings
2022-11-10 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-10 English
8-K
Regulatory Filings
2022-11-10 English
FORM 4
Director's Dealing
2022-10-04 English
8-K
Regulatory Filings
2022-10-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.